Digital Therapeutics
December 3 - 4, 2018 - New York MA USCBI a division of UBM Americas
jkuchinski@cbinet.com
Phone:339-298-2112
Collaborate on Standards in Terminology, Regulations, Clinical Quality, and Data Collection CBI’s Digital Therapeutics will bring together the senior stakeholders developing groundbreaking treatments to collaborate to chart a path forward for broad adoption of next generation therapies. This year’s event will allow you to convene with industry thought leaders to overcome regulatory, development, software, business and legal challenges to ensure cutting edge treatments become commonplace. KEY INSIGHTS AND TAKEAWAYS: Gain strategies to ensure data integrity and software interoperability Prepare for regulatory approaches to digital therapeutics and ensure seamless therapeutic approval in all regions Establish payer approval for digital therapeutics and uncover changing business models Collaborate on standard definitions and approaches to what constitutes a digital therapeutic Reach consensus on clinical standards in digital therapeutic development